ATP-binding cassette (ABC) proteins transport a diverse collection of substrates. It is presumed that these proteins couple ATP hydrolysis to substrate transport, yet ATPase activity has been demonstrated for only a few. To provide direct evidence for such activity in Ste6p, the yeast ABC protein required for the export of a a-factor mating pheromone, we established conditions for purification of Ste6p in biochemical quantities from both yeast and Sf9 insect cells. The basal ATPase activity of purified and reconstituted Ste6p (V max ‫؍‬ 18 nmol/ mg/min; K m for MgATP ‫؍‬ 0.2 mM) compares favorably with several other ABC proteins and was inhibited by orthovanadate in a profile diagnostic of ABC transporters (apparent K I ‫؍‬ 12 M). Modest stimulation (ϳ40%) was observed upon the addition of a a-factor either synthetic or in native form. We also used an 8-azido-[␣-32 P]ATP binding and vanadate-trapping assay to examine the behavior of wild-type Ste6p and two different double mutants (G392V/G1087V and G509D/G1193D) shown previously to be mating-deficient in vivo. Both mutants displayed a diminished ability to hydrolyze ATP, with the latter uncoupled from pheromone transport. We conclude that Ste6p catalyzes ATP hydrolysis coupled to a a-factor transport, which in turn promotes mating.
Members of the ATP-binding cassette (ABC) 1 superfamily share a conserved architecture consisting of two homologous halves, each containing a transmembrane domain and a nucleotide binding domain (NBD) . A number of the mammalian family members play a central role in several disease states including Stargardt's macular dystrophy (1), adrenoleukodystrophy (2), cystic fibrosis (3), Zellweger syndrome (4), and multidrug resistance to cancer chemotherapy (5) . Extensive work on the function of these and other ABC transporters has yielded two important conclusions: 1) they transport a wide array of substrates, including ions, carbohydrates, amino acids, phospholipids, and peptides; and 2) nucleotide binding and/or hydrolysis modulates this transport (for reviews see Refs. 6 and 7).
Ste6p, an ABC transporter found in the yeast Saccharomyces cerevisiae, is required for the export of a-factor mating pheromone, a carboxymethylated and isoprenylated dodecapeptide (8) . Although it is believed that Ste6p couples nucleotide binding and hydrolysis to a-factor transport, no direct evidence for this exists. Indeed, although NBDs are the hallmark feature of ABC transport proteins, direct evidence for nucleotide binding or ATP hydrolysis (ATPase activity) has been obtained for only a few family members (including HisQMP 2 , MalFGK 2 , ABCR, CFTR, Pgp, MRP1, and MRP2 (9 -15)). One reason for this paucity lies in the challenge these large and complex proteins offer in terms of purification. In this study, we developed a procedure to purify Ste6p to homogeneity from both yeast and Sf9 insect cells. Using this purified material, we characterized the ATPase activity of both the wild-type transporter and two different mutants, shown previously to be a-factor transportdefective in vivo (16, 17) . This work led us to conclude that Ste6p ATPase activity is linked to a-factor transport.
MATERIALS AND METHODS
Yeast Strains and Plasmids-Yeast were routinely grown at 30°C in synthetic complete dropout media (8) . Strain SM4385 (MATa ura3 his1 pdr1⌬::hisG yor1⌬::hisG snq2⌬::hisG pdr10⌬::hisG pdr11⌬::hisG ycf1⌬::hisG pdr3⌬::hisG pdr5⌬::hisG pdr15⌬::hisG ste6⌬5(882) (8 -1290) ) was created by deletion of STE6 from a MATa derivative of AD1-9 (gift of A. Goffeau, Université Catholique de Louvain). Deletion of STE6 codons 8 -1290 was accomplished by a two-step gene replacement (pop-in/pop-out) strategy utilizing MscI linearized yeast integrating plasmid pSM882 (URA3 ⌬ste6 -5), followed by excision via selection on 5-fluororotic acid (18) . The chromosomal deletion of STE6 performed by this procedure was confirmed by loss of mating competence in a patch mating assay (8) . Transformants of SM4385 were created by published methods (19) .
The ABC proteins used in this study were encoded on the multicopy vector pSM217 (2 of URA3) (16) ). The plasmids (Table I) were constructed by standard cloning techniques (20) or recombinational cloning (21), using either pSM672 (22) or pMDR2000XSG (23) as the original source of STE6 or MDR1, respectively. To normalize protein expression levels, each gene was placed under the control of the native STE6 promoter. All of the encoded proteins contain a C-terminal extension that includes a triply iterated HA epitope tag ((YPYDVPDYA) 3 ) followed by a decahistidine sequence (His 10 ). The wild-type STE6 phenotype of SM4385 was fully restored upon transformation with plasmid pSM1483.
Yeast Membrane Preparation-Membranes were prepared from spheroplasts as described previously (24, 25) . Briefly, spheroplasts were thawed rapidly and diluted to 100 A 600 /ml in Buffer A (50 mM Tris HCl (pH 7.5), 50 mM KCl, 1 mM EDTA, and 0.5 mM dithiothreitol) containing fresh protease inhibitors (1 g/ml aprotinin, 100 g/ml chymostatin, 0.5 g/ml leupeptin, 1 g/ml pepstatin, 17 g/ml phenylmethylsulfonyl fluoride, and 0.1 mM diisopropyl fluorophosphate). After Dounce homog-enization (typically 100 strokes), debris was removed by a low speed spin (3000 ϫ g for 10 min) and the membrane pellet (100,000 ϫ g for 60 min) was resuspended in Buffer A. Protein concentration was determined by Bradford assay (Bio-Rad). All steps were performed at 4°C or on ice. Expression was confirmed by SDS-PAGE and immunoblotting with a mouse monoclonal anti-HA antibody conjugated to horseradish peroxidase (Roche Molecular Biochemicals; clone 12CA5) followed by enhanced chemiluminescence (ECL, Pierce).
Sf9 Membrane Preparation-The STE6 gene was derived from the yeast plasmid pSM1483 (Table I ) and directly cloned into the baculovirus transfer vector pBlueBac 4.5 (Invitrogen), yielding pBlueBac-STE6. The generation of recombinant baculovirus and maintenance of Spodoptera frugiperda (Sf9 ovarian) insect cells was according to the procedures described by Invitrogen (Carlsbad, CA) with reagents from Life Technologies, Inc.). Briefly, insect cells were maintained in Grace's insect media supplemented with 10% (v/v) fetal bovine serum and antibiotics (100 units/ml penicillin and 100 g/ml streptomycin) at a density between 0.6 and 2 million cells/ml in Bellco (Vineland, NJ) suspension flasks (0.01-5 liter). For protein expression, cells were infected with recombinant baculovirus carrying the yeast STE6 gene (5 viral particles/cell) and harvested 48 h later. Harvested cells were washed with phosphate-buffered solution (pH 7.5), suspended in 50 mM Tris HCl (pH 7.5), 50 mM mannitol, 2 mM EGTA, 2 mM dithiothreitol, 1 g/ml aprotinin, and 0.5 g/ml leupeptin, and stored at Ϫ80°C. Sf9 cells were thawed rapidly, swollen on ice for 30 min, and lysed by Dounce homogenization. Membranes were collected and assayed for protein concentration and expression as above
Immunoprecipitation-Membranes (100 g) were solubilized at 0.15 mg/ml in a buffer containing 20 mM Tris HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 1 g/ml aprotinin, and 0.5 g/ml leupeptin at 4°C for 30 min. Epitope-tagged proteins were immunoprecipitated with 0.2 g of rat monoclonal anti-HA antibody (Roche Molecular Biochemicals; clone 3F10), according to published methods (16, 26) .
Purification-Membranes (ϳ20 mg) were washed three times with 5 ml of Buffer A (as above) and solubilized at 10 mg/ml in Buffer B (50 mM Tris HCl (pH 7.5), 50 mM KCl, 1 mM EDTA, 0.5 mM dithiothreitol, 10% (v/v) glycerol, 0.2% (w/v) Escherichia coli phospholipid (Avanti Polar Lipids), 1% (w/v) dodecyl maltoside (Calbiochem), and 20 mM imidazole) containing protease inhibitors (as above) at 4°C for 60 min. Insoluble material was eliminated (100,000 ϫ g for 60 min), and the supernatant (ϳ2 ml) was added to Ni-NTA resin (Qiagen; 100 l of 50% slurry) previously washed and equilibrated in Buffer B. The suspension was mixed for 60 min at 4°C and then added to a gravity flow column. The unbound fraction was collected, the resin was washed with 100-column volumes of Buffer B supplemented to 40 mM imidazole, and purified protein was eluted with 10 volumes of the same buffer containing 200 mM imidazole. An amido black 10B assay (27) was employed to determine protein concentration; purity was confirmed by silver staining (Bio-Rad) and immunoblotting of duplicate gels.
Reconstitution-Purified protein was reconstituted by detergent dilution (28) . Liposomes were prepared at room temperature in a bath sonicator from about 25 mg of hydrated E. coli phospholipid plus 50 mM Tris HCl (pH 7.5) and 50 mM KCl. After a brief spin to clarify the suspension, the sonicated liposomes were transferred to an Eppendorf tube and octyl ␤-D-glucopyranoside (Calbiochem) added to 3.75% (w/v). One volume of this mixture was added to two volumes of solubilized protein and incubated at room temperature for 20 min. Proteoliposomes were formed by rapidly diluting the mixture about 150-fold into a buffer containing 50 mM Tris HCl (pH 7.5), 50 mM KCl, 1 g/ml aprotinin, and 0.5 g/ml leupeptin and collected by centrifugation (180,000 ϫ g for 60 min). This method is presumed to allow the random insertion of protein, generating proteoliposomes with an equal distribution of inside-out and right side-out orientations (29, 30) . Protein recovery was measured by an amido black 10B assay (27) and validated by quantitative immunoblot analysis. Reactions were incubated at 37°C for 4 min; after the addition of 10 mM ATP to reduce nonspecific binding, samples were irradiated with UV light (365 nm) for 10 min at a fixed distance of 5 cm. Labeled proteins were separated by SDS-PAGE and visualized by autoradiography (Kodak X-OMAT Film and/or Fuji phosphorimager). The appropriate bands were quantified (arbitrary units) using Fuji Image Gauge V3.3 imaging software. Vi was prepared as detailed by Goodno (31) , and the concentration of stock solutions was determined by molar absorbance ( 268 nm ϭ 3600 M
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). ATPase Assay-Proteoliposomes were assayed for nucleotide hydrolysis at 37°C in Buffer C (as above) containing 5-10 Ci of [␣-
32 P]ATP. At defined time points, aliquots were removed, quenched by addition of 2.5% (w/v) SDS, and spotted on a polyethyleniminecellulose plate (J. T. Baker). Hydrolyzed [␣-32 P]ADP was separated from [␣-32 P]ATP by thin-layer chromatography in 1 M formic acid and 0.5 M LiCl. Radiolabeled nucleotides were visualized by a Fugi phosphorimager and quantified (as above). Specific activity was recorded as the Vi-sensitive (0.3 mM) activity above background. Stock solutions of synthetic a-factor (Sigma) were prepared in methanol; biological activity was confirmed as before (8) .
RESULTS
Azido-ATP Binding and Vi-trapping of Ste6p in Yeast
Membranes-Yeast are known to express many membrane ATPases of high specific activity, including a number of ABC transporters (6). To minimize this background ATPase activity, we employed a strain deleted for ten different ABC transporters, including Ste6p (see under "Materials and Methods"). Wildtype Ste6p and two distinct a-factor transport-defective Ste6p mutants (16, 17) were individually expressed, and the capacity of each crude membrane extract to bind and hydrolyze ATP was evaluated in parallel with samples of human P-glycoprotein (Pgp) encoded by MDR1 and expressed in the same yeast strain. "Orthovanadate-trapping" was exploited to examine nucleotide processing. Acting as a structural analog of the bipyrimidal inorganic phosphate (P i ) transition state (32, 33) , orthovanadate (Vi) can arrest the hydrolytic cycle of an ATPase at an intermediate point (e.g. Ste6p⅐MgADP⅐Vi), allowing the entire population to accumulate in a single "trapped" state. When done in conjunction with a photolabile ATP analog, such as 8-azido-[␣-
32 P]ATP, irradiation with UV light can cross-link the trapped nucleotide to the peptide backbone. This generates a highly stable radioactive species that can be enriched by immunoprecipitation, separated by gel electrophoresis, and transferred to a nitrocellulose membrane for autoradiography (Fig. 1a) and immunoblotting (Fig. 1b) . Analysis of two inde- Table I ) encoding an empty vector (⌬), wild-type Ste6p (WT), a Ste6p Walker A mutant (A), a Ste6p signature sequence mutant (SS), or Pgp. Epitope-tagged ABC proteins were immunoprecipitated, separated by SDS-PAGE, and transferred to nitrocellulose. The nitrocellulose membrane was first exposed to a Fuji phosphorimaging screen (a) and then immunoblotted (b). 
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This study pendent experiments revealed a higher mean level of Vi-dependent nucleotide trapping for both wild-type Ste6p and Pgp relative to the Walker A and signature sequence Ste6p mutants (in arbitrary units; 100 and 165 versus 6 and 47, respectively), indicating that each mutant had a diminished ability to hydrolyze ATP. The first mutant harbored a Gly to Val substitution in the Walker A motif (GX 4 GK(S/T) (34)) of each NBD (G392V/ G1087V), while the second carried a Gly to Asp substitution within the ABC signature sequence (LSGGQ (35) ; also referred to as the C motif) of each NBD (G509D/G1193D). Reduced Vi-trapping, together with the previous observation that neither double mutant transports a-factor in vivo (Ͻ0.0001% of wild type (16, 17) ) suggests that Ste6p catalyzes ATP hydrolysis coupled to a-factor transport. Furthermore, the observation that the signature sequence double mutant maintains roughly one half of its hydrolytic activity argues that these substitutions may perturb the coupling of energy to transport. Purification of Ste6p from Yeast Membranes-To validate these findings using purified material, and to further analyze Ste6p ATPase activity, we developed a procedure to purify biochemical quantities of this transporter from yeast membranes. Quantitative immunoblotting confirmed that about 1-2% of the total yeast membrane protein could be attributed to epitope-tagged Ste6p (data not shown). Yeast membranes were solubilized with 1% dodecyl maltoside in the presence of 10% glycerol and 0.2% E. coli lipid, and Ste6p was purified by adsorption to a Ni-affinity column (36) . This procedure routinely yielded 50 ng of Ste6p/A 600 yeast (1-5 ϫ 10 7 cells) at a purity of Ͼ90% as determined by silver staining (Fig. 2) corresponding to a final recovery of ϳ10 -15% of the total available Ste6p. Similar yields and purification were seen for both Pgp and the Ste6p signature sequence mutant while lower amounts of the Walker A mutant were recovered (Fig. 2) . The low yield of the Walker A mutant may reflect an increased susceptibility to degradation during purification, since this mutant compared favorably with wild type in terms of membrane expression (Fig.  1) , detergent solubility (data not shown), and column affinity (Fig. 2) .
Azido-ATP Binding and Vi-trapping of Purified and Reconstituted Ste6p-To assess the functional status of the purified and reconstituted ABC transport proteins, proteoliposomes formed by detergent dilution (28) were subjected to azido-ATP binding and Vi-trapping. Labeled proteins were separated by gel electrophoresis and transferred to a nitrocellulose membrane for autoradiography. Immunoblot analysis was performed on the same membrane to confirm protein specificity and ascertain recovery. After correction for protein content, the results resembled those seen earlier with crude membranes (Fig. 1) . Pgp and Ste6p displayed high levels of Vi-trapping relative to the signature sequence and Walker A mutants (G509D/G1193D and G392V/G1087V, respectively; Table II ). These results demonstrate that the functional competence of both wild-type Ste6p and Pgp is retained after purification and reconstitution and confirm the earlier inferences that the wildtype Ste6p ATPase is linked to a-factor transport and that the signature sequence mutant has abnormal coupling.
ATP Hydrolysis by Purified and Reconstituted Ste6p-A distinguishing characteristic of other ABC transporters is that a basal ATPase activity can be enhanced by the presence of substrates (9 -11, 14, 15, 37, 38) , and we sought to evaluate this phenomenon with regard to Ste6p. Accordingly, Ste6p proteoliposomes were incubated with and without 10 M synthetic a-factor in the presence of [␣-32 P]ATP, and the formation of [␣-32 P]ADP was monitored (Table II) . We found that the Visensitive basal ATPase activity of Ste6p was 18 nmol/mg/min. The a-factor stimulation observed (ϳ40%) was similar to that observed for MRP2 (50%; (14)), but less than the 2-to 6-fold activation reported for other ABC transporters (see below and Refs. 9 -11, 15, 37-40) . Similar results were obtained using both synthetic a-factor titrated over a broad range (1 pM-1 mM) and a crude preparation of a-factor isolated from the culture media of yeast MATa cells (data not shown). The ATPase activity of the Ste6p signature sequence mutant was reduced relative to wild type and displayed only a slight stimulation in the presence of a-factor (Table II) . Pgp proteoliposomes assayed in parallel, displayed a Vi-sensitive basal ATPase activity of 400 nmol/mg/min that was stimulated 6-fold in the presence of 10 M verapamil (Table II) . That these latter values are in good agreement with published reports for Pgp (37, 39 -41) suggests that our assay conditions were suitably devised to detect substrate stimulation.
A second distinguishing characteristic of ABC transporters appears to be an inhibition by Vi (6, 7) . For example, the ATPase activity of Pgp is almost completely inhibited by Vi in the low millimolar range with an apparent K I in the low micromolar range (37, 39, 42) . A similar test with both wild-type . The unbound (UB) fraction was collected, the resin was washed (W), and purified protein was eluted (E). For each preparation, a small aliquot of each fraction (0.04% of UB, 0.4% of W, and 4% of E) was loaded onto duplicate gels for silver staining (a) and immunoblotting (b).
and signature sequence mutant Ste6p proteoliposomes showed that half-maximal inhibition of ATP hydrolysis was achieved at Vi concentrations of 12 and 10 M, respectively (Table II) . These values not only compare favorably with those measured previously for Pgp (37, 39, 42) but also to those of our preparation of Pgp (14 M). This strongly suggests that the fundamental hydrolytic mechanism of both wild-type and mutant Ste6p behaves in a manner consistent with the highly conserved nature of the ABC superfamily.
Characterization of Ste6p Expressed in Sf9 Insect Cells-The low level of a-factor stimulation observed could reflect prior activation of the Ste6p ATPase activity since the MATa strain from which Ste6p was purified produces a-factor constitutively. To test this hypothesis, we expressed Ste6p in Sf9 insect cells, thus precluding its interaction with a-factor or any other endogenous constituent unique to yeast. As in the yeast system, we initially verified the hydrolytic capacity of Ste6p in Sf9 membranes by azido-ATP binding and Vi-trapping (data not shown). This did not require enrichment by immunoprecipitation despite similar levels of Ste6p expression in both yeast and Sf9 cells (data not shown), suggesting that Sf9 membranes have a lower background ATPase activity than do yeast. We were also able to purify epitope-tagged Ste6p from Sf9 membranes (Fig. 3a) using conditions established for the recovery of ABC transporters expressed in yeast. This procedure routinely yielded about 600 -700 ng of Ste6p/ml culture (1.6 ϫ 10 6 cells). The estimated purity (Ͼ95%) and calculated recovery (10%) of Ste6p from Sf9 membranes compared favorably with that from yeast (see above). When proteoliposomes containing Ste6p purified from Sf9 cells were examined, Vi-trapping revealed the expected Ste6p specific signal (Fig. 3c) , while an ATPase assay measured a Vi-sensitive activity (V max ϭ 18 nmol/mg/min and K m for MgATP ϭ 0.2 mM; Fig. 3e ) in good accord with those seen earlier in yeast (Table II) . This argues that the original yeast preparation was not activated prematurely by a-factor and suggests a model in which a-factor substrate alone need not markedly stimulate the rate of Ste6p-catalyzed ATP hydrolysis.
DISCUSSION
Purification of Active Ste6p-A major obstacle to fully understanding the structure and function of Ste6p, and ABC transporters in general, has been the difficulty in purification of biochemical quantities of active protein. In an attempt to overcome this barrier, we used conditions that might be expected to preserve native activity, including solubilization with a nonionic detergent in the presence of both exogenous lipid and the chemical chaperone glycerol. Following reconstitution, Ste6p had a Vi-sensitive basal ATPase activity of 18 nmol/mg/min at 37°C (Table II and Fig. 3e) , a value similar to that of the ABC transporters ABCR, CFTR, MRP1, and MRP2 (11, 12, 14, 15 ).
We also found that Vi inhibited Ste6p in a profile diagnostic of ABC transporters (Table II; (6, 7) ).
To ensure that these conditions were suited to the recovery of functional material, we also used the same protocol to analyze Pgp, both because its ATPase activity has been well characterized (37, 39 -41) and because when compared with other members of the ABC family, Ste6p is most closely related to the mammalian multidrug resistance proteins in both structure (ϳ60% amino acid conservation compared with Pgp (43)) and function (transport of hydrophobic substrates (5)). Indeed, our protocol generated fully active Pgp (as above), suggesting that these conditions protect the native activity of Ste6p. This success also argues that yeast, in particular S. cerevisiae, should provide an excellent vehicle for the expression of other ABC transporters.
Ste6p ATPase Is Linked to a-Factor Transport-To identify FIG. 3 . Purification and activity of Ste6p expressed in Sf9 insect cells. Sf9 membranes expressing Ste6p were used for purification (as in Fig. 2) . A small aliquot of each fraction (0.04% of UB, 0.4% of W, and 4% of E) was loaded onto duplicate gels for silver staining (a) and immunoblotting (b). Reconstituted protein was tested for azido-ATP binding and Vi-trapping (c) and immunoblotted (d). The Vi-sensitive (0.3 mM) rate of ATP hydrolysis was measured as a function of MgATP concentration; mean Ϯ S.D. for four independent trials (e). V max and K m were calculated from the best-fit linear regression of a LineweaverBurk plot (inset). the role of ATP hydrolysis in the transport mechanism of Ste6p, we examined Walker A and signature sequence mutants known to be defective in a-factor export (16, 17) . The Walker A motif (GX 4 GK(S/T) (34) ) is common to a wide variety of nucleotide binding proteins, including several non-ABC transporters, and is expected to comprise a nucleotide phosphate-binding loop (i.e. the P-loop (44)). The signature sequence (LSGGQ), diagnostic for ABC transporters (35) , is likely outside of the binding pocket and may influence both nucleotide binding (45) and energy coupling (46) . The first Gly in the A motif and the second Gly in the signature sequence are critical to Ste6p function since mutation of either in both NBDs (G392V/ G1087V or G509D/G1193D) eliminates a-factor transport (Ͻ0.0001% of wild type (17)). We found that both of these double mutants displayed a diminished ability to hydrolyze ATP ( Fig. 1 and Table II ), providing direct evidence that wildtype Ste6p catalyzes ATP hydrolysis linked to a-factor transport. Moreover, we conclude that the relative disparity between the capacity of the signature sequence mutant to hydrolyze ATP and its failure to transport a-factor represents an uncoupled phenotype. Is Ste6p ATPase Sufficient for Its Biological Activity?-Previous work on ABC transporters (such as HisQMP 2 , MalFGK 2 , ABCR, Pgp, MRP1, and MRP2 (9 -11, 37, 38) ) has shown that natural substrates stimulate ATP hydrolysis. For this reason, one might predict that the addition of pheromone to purified and reconstituted Ste6p would significantly stimulate the ATPase activity. However, stimulation of Ste6p was modest at best, raising the question of whether its inherently low activity is sufficient to yield physiological concentrations of extracellular a-factor. Based on previous studies regarding Ste6p expression and trafficking (47) (48) (49) , and work presented here, we calculate that at any point in time there are about 100 to 1000 molecules of Ste6p present at the plasma membrane where transport is presumed to occur. Assuming that Ste6p exports one molecule of a-factor for every two molecules of ATP hydrolyzed (one at each NBD (10, 16, 50 -52)), we reason that each Ste6p protein exports roughly 50 molecules of a-factor in its lifetime. At this rate, an actively growing culture of yeast (containing ϳ1 ϫ 10 7 cells/ml) will generate an extracellular concentration of a-factor in the range of 1-10 nM within the span of one doubling time (ϳ2 h). These values compare well with the nanomolar range required to elicit a biological response (8) . Equally or perhaps more importantly, these values are also on par with the concentration of a-factor observed in the culture media of actively growing MATa cells (53) . For this reason, we suggest that Ste6p possesses an inherently low ATPase activity that is necessary for the transport mechanism and sufficient to generate physiological concentrations of extracellular a-factor.
